Clinical Trial Update: A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients

View source ↗

Summary

This clinical trial update describes a prospective controlled study evaluating serum suPAR levels in CsA-treated patients with focal segmental glomerulosclerosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis

Drugs mentioned

• Cyclosporine A (cyclosporine)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: FSGS | Status: UNKNOWN